Results 111 to 120 of about 79,172 (273)
Changes in mastectomy rates at a Brazilian public hospital over 20 years (1989 to 2008)
São Paulo Medical JournalCONTEXT AND OBJECTIVE: Recently, breast-conserving surgery (BCS) has been replacing mastectomy for breast cancer treatment. The aim of this study was to evaluate the changes in mastectomy and BCS rates and the factors relating to these shifts. DESIGN AND
Débora Balabram +6 more
doaj +1 more source
Attitudes toward mastectomy : the development of a measurement scale [PDF]
, 1977 The central purposes of this study were to develop a valid and reliable instrument to measure attitudes toward mastectomy and to determine the number and nature of the variables contained within the instrument.
NC DOCKS at The University of North Carolina at Greensboro +1 more
core
An Update on Early‐Onset Breast Cancer: Incidence, Risk Factors, Genetic Testing, and Treatment
Computational and Systems Oncology, Volume 6, Issue 1, December 2026.ABSTRACT Early‐onset breast cancer presents in patients typically under the age of 40, while very early‐onset breast cancer is usually viewed as breast cancer occurring before the age of 35. Early‐onset breast cancer demonstrates specific molecular properties and has worse outcomes compared to its late‐onset breast cancer counterpart.
Leila Jahangiri
wiley +1 more source
International Journal of Cancer, Volume 159, Issue 4, Page 1056-1067, 15 August 2026.Neoadjuvant endocrine therapy (NET) can help prevent metastases and improve survival in patients with hormone receptor‐positive (HR+) breast cancer. Identifying which HR+ patients will benefit from NET, however, remains challenging. Here, in a patient cohort in the Netherlands, the authors evaluated tumor‐stroma ratio (TSR) and magnetic resonance ...
Layla Andour +8 more
wiley +1 more source
Prophylactic Mastectomy -- The Price of Fear
, 1999 editorialhttp://dx.doi.org/10.1056 ...
Weber, Barbara L., Eisen, Andrea
core
Long‐term benefit from adjuvant tamoxifen therapy for ER+ HER2− breast cancer by PR positivity
International Journal of Cancer, Volume 159, Issue 2, Page 450-459, 15 July 2026.What's new? Tamoxifen is a cornerstone of endocrine therapy for estrogen receptor (ER)‐positive/human epidermal growth factor receptor 2 (HER2)‐negative breast cancer. Its long‐term benefits, however, may vary by progesterone receptor (PR) status. Here, using data from the Stockholm tamoxifen trials, the authors evaluated whether PR expression predicts
Anna E. Nordenskjöld +8 more
wiley +1 more source
, 2016 This study explores the role of others in supporting younger women who opt not to reconstruct their breast post-mastectomy. Semi-structured interviews were conducted with six women, diagnosed with breast cancer in their 30s/40s.
Montague, Jane +5 more
core +1 more source
Olaparib‐associated cutaneous vasculitis in a patient with breast cancer
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marcial Álvarez‐Salafranca +3 more
wiley +1 more source
International Journal of Cancer, Volume 159, Issue 1, Page 78-91, 1 July 2026.What's New? Breast cancer is now the most common malignancy among women in sub‐Saharan Africa (SSA). Its impact on survivors’ quality of life and Global Health Status (GHS), however, remains inadequately studied in this setting. Here, using data from the African Breast Cancer‐Disparities in Outcomes (ABC‐DO) study, the authors examined GHS over time in
Shamsudeen Mohammed +10 more
wiley +1 more source